New York Life Investment Management »

Dyne Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $402k 30k 13.30
2023-09-30 $277k 31k 8.96
2023-06-30 $403k 36k 11.25
2023-03-31 $488k 42k 11.52

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
Citadel Advisors
Vanguard Group
VR Adviser
Franklin Resources
Logos Global Management
Vivo Capital
Artal Group
Jennison Associates
Frazier Life Sciences Management
Goldman Sachs Group
Ikarian Capital
Commodore Capital
Dimensional Fund Advisors

View all funds holding Dyne Therapeutics